泓博医药:帕拉米韦是公司的商业化品种之一

Group 1 - The core viewpoint of the article is that Hongbo Pharmaceutical (301230.SZ) has confirmed that Palivizumab is one of its commercialized products, which is suitable for treating influenza caused by common seasonal flu, type A influenza, or type B influenza [1]